ProtoKinetix, Inc. is a research and development stage biotechnology company focused on Anti-Freeze Glycoproteins (AFGPs), trademarked as AAGPs (Anti-Aging Glycoproteins). The company sponsors scientific medical research on the AAGP molecule and is pursuing commercial validation in healthcare markets, including targeted health care solutions. For fiscal year 2024, the company incurred $99,625 in R&D expenses. ProtoKinetix was originally incorporated as RJV Network, Inc. in Nevada in 1999.
Q2 FY2026 — expected 2026-07-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-28 | 2024-12-31 | 0001079973-25-000516 | EDGAR | 26K words |
| 2024-03-20 | 2023-12-31 | 0001079973-24-000403 | EDGAR | — |
| 2023-03-17 | 2022-12-31 | 0001079973-23-000353 | EDGAR | — |
| 2022-03-10 | 2021-12-31 | 0001079973-22-000230 | EDGAR | — |
| 2021-03-05 | 2020-12-31 | 0001079973-21-000148 | EDGAR | — |
| 2020-02-19 | 2019-12-31 | 0001079973-20-000119 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001079973-19-000124 | EDGAR | — |
| 2018-03-09 | 2017-12-31 | 0001079973-18-000141 | EDGAR | — |
| 2017-02-21 | 2016-12-31 | 0001079973-17-000127 | EDGAR | — |
| 2016-03-30 | 2015-12-31 | 0001079973-16-000885 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001079973-25-001708 | EDGAR | 12K words |
| 2025-08-13 | 2025-06-30 | 0001079973-25-001254 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001079973-25-000816 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001079973-24-001493 | EDGAR | — |
| 2024-07-30 | 2024-06-30 | 0001079973-24-001123 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001079973-24-000714 | EDGAR | — |
| 2023-10-18 | 2023-09-30 | 0001079973-23-001455 | EDGAR | — |
| 2023-07-14 | 2023-06-30 | 0001079973-23-000958 | EDGAR | — |
| 2023-05-02 | 2023-03-31 | 0001079973-23-000595 | EDGAR | — |
| 2022-10-31 | 2022-09-30 | 0001079973-22-001380 | EDGAR | — |
| 2022-07-29 | 2022-06-30 | 0001079973-22-000911 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001079973-22-000560 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-11-21 | 0001553350-25-000111 | EDGAR | 1K words |
| 2025-11-17 | 0001079973-25-001778 | EDGAR | — |
| 2025-10-10 | 0001079973-25-001594 | EDGAR | — |
| 2023-02-01 | 0001079973-23-000152 | EDGAR | — |
| 2023-01-04 | 0001079973-23-000012 | EDGAR | — |
| 2022-12-13 | 0001079973-22-001546 | EDGAR | — |
| 2022-03-21 | 0001079973-22-000312 | EDGAR | — |
| 2022-02-14 | 0001079973-22-000154 | EDGAR | — |
| 2021-12-23 | 0001079973-21-001270 | EDGAR | — |
| 2020-06-18 | 0001079973-20-000515 | EDGAR | — |
133 total filings indexed. 101 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001128189 |
| Ticker | PKTX |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Headquarters | Dalton, Ohio |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report